EDX Medical develops comprehensive multi-biomarker test for prostate cancer
Cambridge-based scientists have developed a novel diagnostic approach for prostate cancer detection, utilising advanced biomarker analysis and AI interpretation. The test, developed by EDX Medical Group, aims to transform screening accuracy by simultaneously evaluating over 100 clinically validated biomarkers in both blood and urine samples.